Results 241 to 250 of about 46,055 (312)

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Health Technol Assess
Feng S, McLellan J, Pidduck N, Roberts N, Higgins JP, Choi Y, Izu A, Jit M, Madhi SA, Mulholland K, Pollard AJ, Procter S, Temple B, Voysey M.   +13 more
europepmc   +1 more source

Safety and Efficacy of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus Type B Infections in Children with Systemic Juvenile Idiopathic Arthritis: Prospective Cohort Study. [PDF]

Vaccines (Basel)
Alexeeva E, Dvoryakovskaya T, Kudlay D, Fetisova A, Kriulin I, Krekhova E, Kabanova A, Labinov V, Labinova E, Kostik M.   +9 more
europepmc   +1 more source

Programmable Antigen‐Specific Immunity via Self‐Adjuvanting Nanovaccines Co‐Delivering Immune Modulators

Angewandte Chemie, EarlyView.
The self‐adjuvanting vaccine—comprising a covalent conjugate of antigen and adjuvant—was formulated into cationic lipid nanoparticles smaller than 100 nm to facilitate uptake by immune cells, with supplemental adjuvants incorporated to modulate immune responses.
Keita Ito, Yoshiyuki Manabe, Shino Ohshima, Masatoshi Maeki, Manabu Tokeshi, Hiroshi Inaba, Kazunori Matsuura, Kazuya Kabayama, Yoshie Kametani, Koichi Fukase   +9 more
wiley   +1 more source

Potential Impact of Higher-Valency Pneumococcal Conjugate Vaccines Among Adults in Different Localities in Germany. [PDF]

J Infect Dis
Ellingson MK, Weinberger DM, van der Linden M, Perniciaro S.   +3 more
europepmc   +1 more source

Burden of Pneumococcal Disease in Young Children Due to Serotypes Contained in Different Pneumococcal Conjugate Vaccines in Eight Asian Countries and Territories. [PDF]

Vaccines (Basel)
Huang L, Li X, Eugenia N, Leung J, Hung SA, Cheong EZB, Avila R, Nua W, Choowanich K, Rampal R, Kulkarni N, Daigle D, Taysi BN.   +12 more
europepmc   +1 more source

Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities. [PDF]

Open Forum Infect Dis
Feemster K, Buchwald UK, Banniettis N, Joyce JG, Velentgas P, Chapman TJ, Yildirim I.   +6 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany. [PDF]

Vaccines (Basel)
Huang M, Weaver JP, Elbasha E, Weiss T, Banniettis N, Feemster K, White M, Kelly MS.   +7 more
europepmc   +1 more source

Streptococcus pneumoniae serotype 3 population structure in the era of conjugate vaccines, 2001-2018. [PDF]

Microb Genom
Cella E, Sutcliffe CG, Grant LR, Tso C, Weatherholtz RC, Littlepage S, Becenti L, Jubair M, Simons BC, Harker-Jones M, Reid R, Yazzie D, Santosham M, O'Brien KL, Hammitt LL, Azarian T.   +15 more
europepmc   +1 more source

Correction to: Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities. [PDF]

Open Forum Infect Dis
europepmc   +1 more source